RDLCX
Price
$7.90
Change
+$0.14 (+1.80%)
Updated
Apr 11 closing price
Net Assets
252.26M
RGAFX
Price
$67.19
Change
+$1.06 (+1.60%)
Updated
Apr 11 closing price
Net Assets
260.89B
Ad is loading...

RDLCX vs RGAFX

Header iconRDLCX vs RGAFX Comparison
Open Charts RDLCX vs RGAFXBanner chart's image
Columbia Disciplined Growth C
Price$7.90
Change+$0.14 (+1.80%)
VolumeN/A
Net Assets252.26M
American Funds Growth Fund of Amer R5
Price$67.19
Change+$1.06 (+1.60%)
VolumeN/A
Net Assets260.89B
RDLCX vs RGAFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RDLCX vs. RGAFX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDLCX is a Buy and RGAFX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 261B vs. RDLCX (252M). RGAFX pays higher dividends than RDLCX: RGAFX (0.66) vs RDLCX (0.00). RDLCX was incepted earlier than RGAFX: RDLCX (18 years) vs RGAFX (23 years). RDLCX (1.92) is less costly to investors than RGAFX (0.34). RDLCX is a more actively managed with annual turnover of: 68.00 vs. RGAFX (25.00). RGAFX has a lower initial minimum investment than RDLCX: RGAFX (250) vs RDLCX (2000). RGAFX annual gain was more profitable for investors over the last year : -4.95 vs. RDLCX (-13.87). RGAFX return over 5 years is better than : 48.89 vs. RDLCX (0.52).
RDLCXRGAFXRDLCX / RGAFX
Total Expense Ratio1.810.34532%
Annual Report Gross Expense Ratio1.920.34565%
Fund Existence18 years23 years-
Gain YTD-15.744-9.715162%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets252M261B0%
Annual Yield % from dividends0.000.66-
Returns for 1 year-13.87-4.95280%
Returns for 3 years-8.177.58-108%
Returns for 5 years0.5248.891%
Returns for 10 years-14.0652.40-27%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIMD0.640.12
+23.08%
Ainos
IKT2.070.21
+11.29%
Inhibikase Therapeutics
USAC23.720.78
+3.40%
USA Compression Partners LP
JBL131.94-0.10
-0.08%
Jabil
TRIN13.56-0.25
-1.81%
Trinity Capital